Gulf Pharmaceutical Industries is looking to hire a restructuring adviser after cutting jobs as a ban on the medicine maker’s exports to Saudi Arabia weighs on its finances. The company known as Julphar replaced most of its top management and appointed new board members as it comes under increasing financial strain. The United Arab Emirates-based firm also cut about 150 jobs, or 3 per cent of its workforce, according to a person with knowledge of the plans who asked not to be identified because they are private. Julphar is under growing pressure after Saudi Arabia’s Food and Drug Authority in September banned its products for failing to meet regional standards. Julphar is working with the agency to get the ban lifted. Learn More